Assessing patient-reported outcomes for automated insulin delivery systems: the psychometric properties of the INSPIRE measures.
Adolescent
Adult
Aged
Aged, 80 and over
Blood Glucose
/ analysis
Blood Glucose Self-Monitoring
/ instrumentation
Diabetes Mellitus, Type 1
/ blood
Female
Humans
Insulin
/ administration & dosage
Insulin Infusion Systems
Male
Middle Aged
Pancreas, Artificial
/ standards
Patient Reported Outcome Measures
Patient Satisfaction
/ statistics & numerical data
Psychometrics
/ methods
Registries
/ statistics & numerical data
Surveys and Questionnaires
/ standards
Young Adult
Journal
Diabetic medicine : a journal of the British Diabetic Association
ISSN: 1464-5491
Titre abrégé: Diabet Med
Pays: England
ID NLM: 8500858
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
accepted:
12
02
2019
pubmed:
15
2
2019
medline:
6
2
2020
entrez:
15
2
2019
Statut:
ppublish
Résumé
Participants in clinical trials assessing automated insulin delivery systems report perceived benefits and burdens that reflect their experiences and may predict their likelihood of uptake and continued use of this novel technology. Despite the importance of understanding their perspectives, there are no available validated and reliable measures assessing the psychosocial aspects of automated insulin delivery systems. The present study assesses the initial psychometric properties of the INSPIRE measures, which were developed for youth and adults with Type 1 diabetes, as well as parents and partners. Data from 292 youth, 159 adults, 150 parents of youth and 149 partners of individuals recruited from the Type 1 Diabetes Exchange Registry were analysed. Participants completed INSPIRE questionnaires and measures of quality of life, fear of hypoglycaemia, diabetes distress, glucose monitoring satisfaction. Exploratory factor analysis assessed factor structures. Associations between INSPIRE scores and other measures, HbA Youth, adult, parent and partner measures assess positive expectancies of automated insulin delivery systems. Measures range from 17 to 22 items and are reliable (α = 0.95-0.97). Youth, adult and parent measures are unidimensional; the partner measure has a two-factor structure (perceptions of impact on partners versus the person with diabetes). Measures showed concurrent and discriminant validity. INSPIRE measures assessing the positive expectancies of automated insulin delivery systems for youth, adults, parents and partners have meaningful factor structures and are internally consistent. The developmentally sensitive INSPIRE measures offer added value as clinical trials test newer systems, systems become commercially available and clinicians initiate using these systems.
Identifiants
pubmed: 30761592
doi: 10.1111/dme.13930
pmc: PMC6593869
doi:
Substances chimiques
Blood Glucose
0
Insulin
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
644-652Subventions
Organisme : NIDDK NIH HHS
ID : P30 DK036836
Pays : United States
Informations de copyright
© 2019 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.
Références
Diabetes Technol Ther. 2017 Jul;19(7):410-416
pubmed: 28537437
Psychother Psychosom. 2015;84(3):167-76
pubmed: 25831962
Lancet Diabetes Endocrinol. 2014 Sep;2(9):701-9
pubmed: 24943065
Pediatr Diabetes. 2015 Dec;16(8):592-9
pubmed: 25387433
Diabet Med. 2012 Apr;29(4):526-30
pubmed: 21883443
J Diabetes Sci Technol. 2017 Nov;11(6):1080-1088
pubmed: 28367636
Diabetes Technol Ther. 2017 Jan;19(1):18-24
pubmed: 27982707
Diabetes Technol Ther. 2015 Sep;17(9):657-63
pubmed: 25923812
Diabetes Care. 2004 Nov;27(11):2610-5
pubmed: 15504994
Diabet Med. 2015 May;32(5):601-8
pubmed: 25615888
Diabetes Care. 1987 Sep-Oct;10(5):617-21
pubmed: 3677982
N Engl J Med. 2014 Jul 24;371(4):313-325
pubmed: 24931572
J Diabetes Complications. 2015 May-Jun;29(4):572-7
pubmed: 25765489
Diabet Med. 2019 May;36(5):644-652
pubmed: 30761592
J Diabetes Sci Technol. 2017 Mar;11(2):224-232
pubmed: 27595711
Diabetes Technol Ther. 2016 May;18(5):292-7
pubmed: 26859072
Med Care. 2001 Aug;39(8):800-12
pubmed: 11468499
Diabetes Care. 2017 Nov;40(11):1453-1461
pubmed: 28842523
J Diabetes Sci Technol. 2018 Jul;12(4):792-799
pubmed: 29595061
Diabetes Care. 2016 Jul;39(7):1161-7
pubmed: 27330125
J Diabetes Sci Technol. 2016 Jun 28;10(4):852-8
pubmed: 27234809
Diabetes Technol Ther. 2017 Dec;19(12):723-729
pubmed: 29106311
Qual Life Res. 2008 Jun;17(5):725-35
pubmed: 18427951
Qual Life Res. 2001;10(1):59-70
pubmed: 11508476
Diabetes Manag (Lond). 2011;1(6):627-639
pubmed: 22180760
JAMA. 2016 Oct 4;316(13):1407-1408
pubmed: 27629148
Educ Psychol Meas. 2006 Aug;66(4):687-700
pubmed: 21660203
J Diabetes Sci Technol. 2016 Jun 28;10(4):840-4
pubmed: 26993252
Lancet Diabetes Endocrinol. 2015 Jan;3(1):17-26
pubmed: 25434967